Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Savara Inc | Director | Common Stock | 62.5K | $185K | $2.95 | Dec 12, 2024 | Direct |
LUMOS PHARMA, INC. | Director | Common Stock | 0 | $0 | $1.89 | Dec 12, 2024 | Direct |
PLUS THERAPEUTICS, INC. | Director | Stock Option (Right to Buy) | 3.65K | Sep 11, 2024 | Direct | ||
LUMOS PHARMA, INC. | Director | Stock Option (Right to Buy) | 0 | Dec 12, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
SVRA | Savara Inc | Dec 12, 2024 | 1 | $0 | 4 | Dec 16, 2024 | Director |
(LUMO) | LUMOS PHARMA, INC. | Dec 12, 2024 | 6 | $0 | 4 | Dec 13, 2024 | Director |
PSTV | PLUS THERAPEUTICS, INC. | Sep 11, 2024 | 1 | $0 | 4 | Sep 12, 2024 | Director |
(LUMO) | LUMOS PHARMA, INC. | Jun 5, 2024 | 1 | $0 | 4 | Jun 7, 2024 | Director |
PSTV | PLUS THERAPEUTICS, INC. | Feb 22, 2024 | 1 | $0 | 4 | Feb 26, 2024 | Director |
SVRA | Savara Inc | Dec 14, 2023 | 1 | $0 | 4 | Dec 15, 2023 | Director |
LUMO | LUMOS PHARMA, INC. | May 10, 2023 | 1 | $0 | 4 | May 12, 2023 | Director |
PSTV | PLUS THERAPEUTICS, INC. | Feb 15, 2023 | 1 | $0 | 4 | Feb 17, 2023 | Director |
SVRA | Savara Inc | Dec 13, 2022 | 1 | $0 | 4 | Dec 15, 2022 | Director |
LUMO | LUMOS PHARMA, INC. | May 5, 2022 | 1 | $0 | 4 | May 9, 2022 | Director |
SVRA | Savara Inc | Dec 14, 2021 | 1 | $0 | 4 | Dec 14, 2021 | Director |
PSTV | PLUS THERAPEUTICS, INC. | May 25, 2021 | 1 | $0 | 4 | May 27, 2021 | Director |
LUMO | LUMOS PHARMA, INC. | May 20, 2021 | 2 | $0 | 4 | May 24, 2021 | Director |